| Rank | Clinic Name | Patient Rating | Country | Lead Doctor | experience | Techniques | Best For | Why It’s Ranked | Accreditations |
|---|---|---|---|---|---|---|---|---|---|
| #1 | 4.6 / 5 (514 reviews) | Istanbul, Turkey | 33+ years | Lutetium-177 therapy, Actinium-225 therapy | Advanced prostate cancer with PSMA-targeted therapy | Offers specialized PSMA-targeted therapies with JCI accreditation and collaboration with Johns Hopkins Medicine. Doctors have 40+ publications in tumor biology and targeted therapy. | Planetree's Gold Certificate, International Accreditation System for Interventional Oncology Services (IASIOS) | ||
| #2 | 4.7 / 5 (357 reviews) | Istanbul, Turkey | 25+ years | Lutetium-177 therapy, targeted drugs | Advanced or metastatic cancers | JCI-accredited oncology department with access to advanced targeted drugs and personalized therapy plans. Follows NCCN and ESMO protocols for precise treatment. | International Organization for Standardization, Joint Commission International | ||
| #3 | 4.7 / 5 (132 reviews) | Istanbul, Turkey | 15+ years | Lutetium-177 therapy | Advanced cancer cases requiring precision treatment | Specializes in Lutetium-177 therapy with a dedicated targeted therapy team led by an experienced oncologist. Offers precise diagnostics with 3T MRI and innovative Elekta Versa HD radiotherapy system. | International Organization for Standardization, Joint Commission International | ||
| #4 | 5.0 / 5 (1 review) | Istanbul, Turkey | — | — | Targeted therapy | — | — | — | |
| #5 | 4.6 / 5 (213 reviews) | Istanbul, Turkey | 20+ years | Lutetium-177 therapy | Metastatic colorectal cancer | JCI-accredited hospital with specialized oncology team. Offers Lutetium-177 therapy for targeted cancer treatment. Doctors recommend personalized treatment plans based on molecular test results. | Joint Commission International , Turkish Medical Association (Türk Tabıplerı Bırliği) | ||
| #6 | 4.6 / 5 (126 reviews) | Antalya , Turkey | 26+ years | Targeted therapy, Lutetium-177 therapy | Metastatic and resistant cancers | Follows NCCN and ESMO protocols with a multidisciplinary team approach. Offers personalized treatment plans based on genetic testing. JCI-accredited hospital with 94% patient recommendation rate. | Joint Commission International | ||
| #7 | 4.6 / 5 (473 reviews) | Istanbul, Turkey | — | — | Lutetium-177 therapy | Advanced neuroendocrine tumors | Offers specialized Lutetium-177 therapy for targeted cancer treatment. JCI-accredited oncology hospital with PET-CT and advanced radiotherapy equipment including Trilogy and TrueBeam LINACs. | Joint Commission International , Patient choice in Pediatric Oncology & Hematology Oncology | |
| #8 | 4.5 / 5 (51 reviews) | Istanbul, Turkey | — | — | Brain MRI, Online Consultation with Dermatologist | — | — | Joint Commission International | |
| #9 | 4.9 / 5 (54 reviews) | Istanbul, Turkey | 23+ years | Lutetium-177 therapy, monoclonal antibody therapy, immunotherapy | Pancreatic neuroendocrine tumors | Offers specialized Lutetium-177 therapy and personalized treatment plans based on genetic testing. Doctors have performed 1,100+ procedures with a focus on gastrointestinal cancers. | Turkish Medical Association, International Health Tourism Authorization Certificate | ||
| #10 | 4.4 / 5 (32 reviews) | Istanbul, Turkey | 76+ years | Targeted therapy, Brain MRI | — | — | International Organization for Standardization, Joint Commission International |